14 Jun 2016
Author(s): 
World Health Organizaton (WHO)

In a special issue of the journal Vaccine, guest-edited by WHO, experts focus on the research and development (R&D) pipeline of vaccines against 25 pathogens for which no licensed vaccines currently exist but for which there is high public health importance, as identified by the WHO Product Development for Vaccines Advisory Committee (PDVAC).